7 results on '"Kuang, Yu"'
Search Results
2. Volumetric Modulated Arc Therapy Planning for Primary Prostate Cancer With Selective Intraprostatic Boost Determined by 18F-Choline PET/CT.
- Author
-
Kuang, Yu, Wu, Lili, Hirata, Emily, Miyazaki, Kyle, Sato, Miles, and Kwee, Sandi A.
- Subjects
- *
DIAGNOSIS , *PROSTATE cancer , *CANCER radiotherapy , *POSITRON emission tomography , *PROSTATE cancer treatment , *CHOLINE , *COMPUTED tomography - Abstract
Purpose This study evaluated expected tumor control and normal tissue toxicity for prostate volumetric modulated arc therapy (VMAT) with and without radiation boosts to an intraprostatically dominant lesion (IDL), defined by 18 F-choline positron emission tomography/computed tomography (PET/CT). Methods and Materials Thirty patients with localized prostate cancer underwent 18 F-choline PET/CT before treatment. Two VMAT plans, plan 79 Gy and plan 100-105 Gy , were compared for each patient. The whole-prostate planning target volume (PTV prostate ) prescription was 79 Gy in both plans, but plan 100-105 Gy added simultaneous boost doses of 100 Gy and 105 Gy to the IDL, defined by 60% and 70% of maximum prostatic uptake on 18 F-choline PET (IDL suv60% and IDL suv70% , respectively, with IDL suv70% nested inside IDL suv60% to potentially enhance tumor specificity of the maximum point dose). Plan evaluations included histopathological correspondence, isodose distributions, dose-volume histograms, tumor control probability (TCP), and normal tissue complication probability (NTCP). Results Planning objectives and dose constraints proved feasible in 30 of 30 cases. Prostate sextant histopathology was available for 28 cases, confirming that IDL suv60% adequately covered all tumor-bearing prostate sextants in 27 cases and provided partial coverage in 1 case. Plan 100-105 Gy had significantly higher TCP than plan 79 Gy across all prostate regions for α/β ratios ranging from 1.5 Gy to 10 Gy ( P <.001 for each case). There were no significant differences in bladder and femoral head NTCP between plans and slightly lower rectal NTCP (endpoint: grade ≥ 2 late toxicity or rectal bleeding) was found for plan 100-105 Gy . Conclusions VMAT can potentially increase the likelihood of tumor control in primary prostate cancer while observing normal tissue tolerances through simultaneous delivery of a steep radiation boost to a 18 F-choline PET-defined IDL. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
- Author
-
Kuang-Yu Jen, Ihn Young Song, Banta, Karl Luke, Di Wu, Jian-Hua Mao, and Balmain, Allan
- Subjects
- *
T-cell lymphoma , *MOUSE diseases , *LYMPHOPROLIFERATIVE disorders , *MOLECULAR genetics , *GENETIC mutation , *HORMONE therapy , *DIAGNOSIS - Abstract
T-cell acute lymphoblastic lymphomas commonly demonstrate activating Notch1 mutations as well as mutations or deletions in Fbxw7. However, because Fbxw7 targets Notchi for degradation, genetic alterations in these genes are expected to be mutually exclusive events in lymphomagenesis. Previously, by using a radiation-induced Tp53-deficient mouse model for T-cell acute lymphoblastic lymphoma, we reported that loss of heterozygosity at the Fbxw7 locus occurs frequently in a Tp53-dependent manner. In the current study, we show that these thymic lymphomas also commonly exhibit activating Notch1 mutations in the proline-glutamic acidserine-threonine (PEST) domain. Moreover, concurrent activating Notch 1 PEST domain mutations and single-copy deletions at the Fbxw7 locus occur with high frequency in the same individual tumors, indicating that these changes are not mutually exclusive events. We further demonstrate that although Notch1 PEST domain mutations are independent of Tp53 status, they are completely abolished in mice with germline Fbxw7 haploinsufficiency. Therefore, Notch1 PEST domain mutations only occur when Fbxw expression levels are intact. These date suggest a temporal sequence of mutational events involving these importani cancer-related genes, with Notch1 PES1 domain mutations occurring first, followed by Fbxw7 deletion, and eventually by complete loss of Tp53. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
4. Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit
- Author
-
Yeh, Shin-Joe, Huang, Kuang-Yu, Wang, Tyng-Guey, Chen, Yee-Chun, Chen, Chung-Hwa, Tang, Sung-Chun, Tsai, Li-Kai, Yip, Ping-Keung, and Jeng, Jiann-Shing
- Subjects
- *
DEGLUTITION disorders , *CEREBROVASCULAR disease patients , *INTENSIVE care units , *RISK factors of pneumonia , *LOGISTIC regression analysis , *HOSPITAL admission & discharge , *DIAGNOSIS - Abstract
Abstract: Dysphagia increases the risk of pneumonia in stroke patients. This study aimed to evaluate bedside swallowing screening for prevention of stroke-associated pneumonia (SAP) in acute stroke patients admitted to the intensive care unit (ICU). Consecutive acute stroke patients admitted to the stroke ICU from May 2006 to March 2007 were included. Patients were excluded if they were intubated on the first day of admission or had a transient ischemic attack. A 3-Step Swallowing Screen was introduced since October 2006 and therefore patients were divided into pre-screen and post-screen groups. A binary logistic regression model was used to determine independent risk factors for SAP and in-hospital death. There were 74 and 102 patients included in the pre- and post-screen groups, respectively. Pneumonia was associated with higher National Institutes of Health Stroke Scale (NIHSS) score, older age, nasogastric and endotracheal tube placement. After adjusting for age, gender, NIHSS score and nasogastric and endotracheal tube insertion, dysphagia screening was associated with a borderline decrease in SAP in all stroke patients (odds ratio, 0.42; 95% CI, 0.18–1.00; p =0.05). However, dysphagia screening was not associated with reduction of in-hospital deaths. Systematic bedside swallowing screening is helpful for prevention of SAP in acute stroke patients admitted to the ICU. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
5. The Relationship Between Fluid Accumulation in Ultrasonography and the Diagnosis and Prognosis of Patients with Necrotizing Fasciitis.
- Author
-
Lin, Chun-Nan, Hsiao, Cheng-Ting, Chang, Chia-Peng, Huang, Tsung-Yu, Hsiao, Kuang-Yu, Chen, Yi-Chuan, and Fann, Wen-Chih
- Subjects
- *
NECROTIZING fasciitis , *ULTRASONIC imaging , *DIAGNOSIS , *LENGTH of stay in hospitals , *PROGNOSIS - Abstract
Necrotizing fasciitis is a severe soft-tissue infection with a high mortality rate. There is little literature on the relationship between the ultrasonographic finding of fluid accumulation along the deep fascia and the diagnosis and prognosis of necrotizing fasciitis. This retrospective study showed that when fluid accumulation was present along the deep fascia, patients with clinically suspected necrotizing fasciitis had a higher probability of having necrotizing fasciitis. The ultrasonographic finding of fluid accumulation with a cutoff point of more than 2 mm of depth had the best accuracy (72.7%) for diagnosing necrotizing fasciitis. In regard to the prognosis of necrotizing fasciitis, when fluid accumulation was present along the deep fascia, patients with necrotizing fasciitis had a longer length of hospital stay and were at risk of amputation or mortality. Ultrasonography is a point-of-care imaging tool that facilitates the diagnosis and prognosis of necrotizing fasciitis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Lupus-like membranous nephropathy: Is it lupus or not?
- Author
-
Sam, Ramin, Joshi, Amit, James, Sam, Jen, Kuang-Yu, Amani, Firouz, Hart, Peter, and Schwartz, Melvin
- Subjects
- *
KIDNEY diseases , *SYSTEMIC lupus erythematosus diagnosis , *IMMUNOFLUORESCENCE , *RETROSPECTIVE studies , *CONTROL groups , *GLOMERULONEPHRITIS , *PROGNOSIS , *PATIENTS , *DIAGNOSIS - Abstract
Background: Membranous glomerulonephritis is typically classified as idiopathic or secondary to systemic lupus erythematosus (SLE), hepatitis B, drugs, toxins, other infections, or malignancy. Not infrequently in some patients without a definite diagnosis of SLE, pathologic features of secondary membranous nephropathy are seen e.g., mesangial and/or subendothelial deposits, tubuloreticular inclusions, and full house immunofluorescence. In these patients, there is uncertainty about the etiology, response to therapy, and prognosis of membranous GN. Methods: We retrospectively reviewed the charts of 98 patients with membranous GN at San Francisco General Hospital and John Stroger Hospital of Cook County over a 10-year period. Data were collected and analyzed using SPSS.18. Results: Thirty-nine (40 %) had idiopathic membranous GN (Group 1), thirty-six (37 %) had lupus membranous GN (Group 2) and twenty-three (23 %) had some pathological features of secondary membranous GN, but no definite etiology of membranous GN (Group 3). At baseline (at time of renal biopsy) and after mean follow-up of 3.5 years, the average serum creatinine (in mg/dL) in Group 1 was (1.6 ± 1.0 versus 1.6 ± 1.7), Group 2 was (1.8 ± 2.5 versus 1.2 ± 0.9) and Group 3 was (1.1 ± 0.4 versus 1.27 ± 0.83), respectively. For the same time points, the average urine protein to creatinine ratio (g/g) in Group 1 was (9.8 ± 7.1 versus 5.7 ± 6.7), Group 2 was (4.2 ± 3.9 versus 1.7 ± 2.2), and Group 3 was (7.4 ± 5.7 versus 3.1 ± 3.8). In addition, during the follow-up period, eleven of 39 (28 %) in Group 1, two of 36 (6 %) in Group 2, and three of 23 (13 %) in Group 3 progressed to end-stage renal disease and were started on dialysis. Conclusions: It appears that patients with lupus membranous GN have better renal prognosis than patients with idiopathic membranous GN. The renal prognosis for patients with pathological features of lupus membranous but no diagnosis of systemic lupus (lupus-like membranous GN) falls in between. Further studies are needed to determine if Group 3 patients can (a) definitively be classified as true idiopathic membranous GN or lupus membranous GN or (b) they have a separate disease from either M-type phospholipase A receptor membranous nephropathy or systemic lupus-induced membranous nephropathy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. The Role of High-Resolution Ultrasound in the Diagnosis of a Traumatic Neuroma in an Injured Median Nerve.
- Author
-
Kai-Hua Chen, Kam-Fai Lee, Hung-Chih Hsu, Wei-Chao Huang, Kuang-Yu Hsiao, and Kuan-Ming Fang
- Subjects
- *
NEUROMAS , *ULTRASONIC imaging , *NERVOUS system regeneration , *MEDIAN nerve injuries , *DIAGNOSIS - Abstract
The article presents a case study of a 42-year-old woman who felt numbness over her left fingers and hand after a self-inflicted cutting of the wrist and subsequent tendon and median nerve repair. It notes that the result of her electrodiagnostic testing was normal but the high-resolution ultrasound showed focal swelling in median nerve region that is consistent with a neuroma. It mentions that the patient underwent nerve repair with a nerve graft after neuroma excision during surgery.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.